Case report: Therapeutic approach to secondary polycythemia vera in an adult with eisenmenger syndrome
DOI:
https://doi.org/10.69863/dim.2024.e433Keywords:
Eisenmenger syndrome, hyperviscosity, polycythemia vera, case reportAbstract
BACKGROUND: Secondary Polycythemia Vera due to Eisenmenger Syndrome remains a big challenge, and the reported cases regarding this condition are still scanty.
CASE: This was a case of a 22-year-old girl who, since childhood, had complaints of fatigue most of the time and thus showed more intolerance to heavy physical work. She had a history of a congenital heart defect, with lip and finger cyanosis that increased upon fatigue, and she had undergone Bi-directional Cavo-pulmonary Shunt. Physical examination showed cyanosis with clubbing of fingers with low oxygen saturation. Further diagnosis testing revealed this was a case of Eisenmenger Syndrome due to congenital heart abnormalities, with Polycythemia Vera: Secondary to the diagnosis. The patient also had a hemoglobin level of 21.1g/dL and a hematocrit level of 64.2%. Based on the diagnosis, treatment was given in the form of hydration therapy along with medications. Additionally, phlebotomy was performed. Because the patient improved clinically from the applied treatment, the patient was discharged after 5 days.
CONCLUSION: Early diagnosis, a multidisciplinary approach, and proper interventions are important in the management of Eisenmenger Syndrome and associated Polycythemia Vera to avoid complications and hence improve outcomes.
References
Tefferi A, Barbui T. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol 2023;98(9):1465-1487.doi: 10.1002/ajh.27002. PMID: 37357958
Benevolo G, Marchetti M, Melchio R, et al. Diagnosis and management of cardiovascular risk in patients with polycythemia vera. Vasc Health Risk Manag 2023;19(1):765-778.doi: 10.2147/VHRM.S429995. PMID: 38025519
Barbui T, Thiele J, Gisslinger H, et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J 2018;8(2):15.doi: 10.1038/s41408-018-0054-y. PMID: 29426921
Oechslin E, Mebus S, Schulze-Neick I, et al. The adult patient with eisenmenger syndrome: A medical update after dana point part iii: Specific management and surgical aspects. Curr Cardiol Rev 2010;6(4):363-372.doi: 10.2174/157340310793566127. PMID: 22043213
Diller GP, Lammers AE, Oechslin E. Treatment of adults with Eisenmenger syndrome-state of the art in the 21st century: a short overview. Cardiovasc Diagn Ther 2021;11(4):1190-1199.doi: 10.21037/cdt-21-135. PMID: 34527543
Raedler LA. Diagnosis and management of polycythemia vera: Proceedings from a multidisciplinary roundtable. Am Health Drug Benefits 2014;7(3):S36-47.doi. PMID: 26568781
Rose SS, Shah AA, Hoover DR, et al. Cyanotic congenital heart disease (CCHD) with symptomatic erythrocytosis. J Gen Intern Med 2007;22(12):1775-1777.doi: 10.1007/s11606-007-0356-4. PMID: 17917783
Kaemmerer H, Mebus S, Schulze-Neick I, et al. The adult patient with eisenmenger syndrome: a medical update after dana point part I: epidemiology, clinical aspects and diagnostic options. Curr Cardiol Rev 2010;6(4):343-355.doi: 10.2174/157340310793566154. PMID: 22043211
Tashkandi H, Younes IE. Advances in molecular understanding of polycythemia vera, essential thrombocythemia, and primary myelofibrosis: Towards precision medicine. Cancers (Basel) 2024;16(9):1679.doi: 10.3390/cancers16091679. PMID: 38730632
Broberg CS, Bax BE, Okonko DO, et al. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. J Am Coll Cardiol 2006;48(2):356-365.doi: 10.1016/j.jacc.2006.03.040. PMID: 16843187
DeFilippis AP, Law K, Curtin S, et al. Blood is thicker than water: the management of hyperviscosity in adults with cyanotic heart disease. Cardiol Rev 2007;15(1):31-34.doi: 10.1097/01.crd.0000214959.82120.97. PMID: 17172881
Van De Bruaene A, Delcroix M, Pasquet A, et al. Iron deficiency is associated with adverse outcome in Eisenmenger patients. Eur Heart J 2011;32(22):2790-2799.doi: 10.1093/eurheartj/ehr130. PMID: 21606083
Diller GP, Dimopoulos K, Broberg CS, et al. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J 2006;27(14):1737-1742.doi: 10.1093/eurheartj/ehl116. PMID: 16793921
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Rahmatan Lil Alamin, Fajar Maulana Raharjo, Michelle Gunawan, Shinta Oktya Wardhani
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
